Skip to main content
HLN
NYSE Industrial Applications And Services

Haleon Reports Strong 2025 Profit & Cash Flow, Initiates £500M Share Buyback for 2026

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$10.57
Mkt Cap
$48.739B
52W Low
$8.71
52W High
$11.42
52W Position info
21% above low
Off High info
7.4% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

HLN sits 21% above its 52-week low of $8.71.

Summary

Haleon plc announced preliminary full-year 2025 results, reporting strong organic operating profit growth and free cash flow, alongside a 7.6% dividend increase and a new £500 million share buyback program for 2026.


Key Events · Earnings and Guidance · HLN

  • Strong 2025 Financial Performance

    Organic operating profit grew 10.5% with 160bps of margin expansion, and free cash flow reached £1.9 billion, reflecting robust operational efficiency.

  • Increased Shareholder Returns

    The Board proposed a 7.6% increase in the total 2025 dividend to 7.1p per share and announced a new £500 million share buyback program for 2026.

  • Mixed Revenue Growth and Outlook

    Organic revenue grew 3.0% in 2025, which was below the medium-term target of 4-6%. The FY 2026 organic revenue growth is expected to be 3-5%.

  • Productivity Initiatives Detailed

    The new operating model, previously announced in January 2026, is expected to result in annualised gross cost savings of £175m-200m over the next two years.


Analysis · HLN · Industrial Applications And Services

Haleon's preliminary full-year 2025 results demonstrate robust operational efficiency and cash generation, with organic operating profit growing 10.5% and free cash flow reaching £1.9 billion. While organic revenue growth of 3.0% was at the lower end of its medium-term guidance and 2026 revenue guidance remains slightly below the long-term target, the company's commitment to shareholder returns is evident through a 7.6% dividend increase and the initiation of a substantial £500 million share buyback program for 2026. This significant capital allocation decision signals strong management confidence in future performance and financial health, despite near-term consumer environment challenges. Investors should monitor the execution of the new operating model and productivity initiatives, which are expected to deliver significant cost savings and support future profit growth.

At the time of this filing, HLN was trading at $10.57 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $48.7B. The 52-week trading range was $8.71 to $11.42. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HLN - Latest Insights

HLN
Jun 29, 2026, 6:22 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.26
Real-time Price: $10.26 info
Change: +$0.995 (+11%) info
Market Cap: $44.579B info
HLN
Jun 22, 2026, 6:42 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $8.84
Real-time Price: $10.26 info
Change: +$1.42 (+16%) info
Market Cap: $44.579B info
HLN
Jun 08, 2026, 3:59 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $8.91
Real-time Price: $10.26 info
Change: +$1.35 (+15%) info
Market Cap: $44.579B info
HLN
Jun 01, 2026, 6:16 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $9.02
Real-time Price: $10.26 info
Change: +$1.24 (+14%) info
Market Cap: $44.579B info
HLN
Mar 13, 2026, 9:59 AM EDT
Filing Type: 20-F
Importance Score:
8
Price at Filing: $10.15
Real-time Price: $10.26 info
Change: +$0.110 (+1%) info
Market Cap: $44.579B info